For citations:
Chashkina M.I., Andreev D.A., Kozlovskaya N.L., Salpagarova Z.K., Suvorov A.Yu., Suchkova S.A., Bykova A.A., Syrkin A.L. Safety performance of rivaroxaban versus warfarin in patients with atrial fibrillation and advanced chronic kidney disease. Kardiologiia. 2020;60(11):94–100. https://doi.org/10.18087/cardio.2020.11.n1322
Views PDF (Eng): 219